Committed change of real-time quantitative PCR to droplet digital PCR for monitoring < em > BCR < /em > :: < em > ABL1 < /em > transcripts in tyrosine kinase inhibitor treated CML

CONCLUSION: ddPCR was proven to be a highly sensitive method with the potential to overcome some limitations of traditional RQ-PCR, and has the potential of being a valuable tool for monitoring BCR::ABL1 transcripts in CML during TKI therapy. (163 words).PMID:37695125 | DOI:10.1080/16078454.2023.2256199

Source: Hematology - September 11, 2023 Category: Hematology Authors: Adcharee Kongruang Nittaya Limsuwanachot Sutada Magmuang Prapatsorn Areesirisuk Pimjai Niparuck Teerapong Siriboonpiputtana Budsaba Rerkamnuaychoke Source Type: research